Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CXCR4”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Early research (Phase 1)Study completedNCT00063804
What this trial is testing

Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected Men

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 44
Early research (Phase 1)UnknownNCT04727008
What this trial is testing

CXCR4 Modified Anti-BCMA CAR T Cells for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sichuan University 12
Testing effectiveness (Phase 2)UnknownNCT00299897
What this trial is testing

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

Who this might be right for
HIV InfectionsHuman Immunodeficiency Virus
Samaritan Pharmaceuticals, Inc 60
Not applicableLooking for participantsNCT05519735
What this trial is testing

Lymphatic Organs and Myocardium After Myocardial Infarction

Who this might be right for
Myocardial InfarctionMyocardial InjuryMyocardial Inflammation
Wuerzburg University Hospital 57
Not applicableLooking for participantsNCT06690736
What this trial is testing

Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases

Who this might be right for
CXCR4-related DiseaseTumorPositron Emission Tomography+1 more
Tianjin Medical University 200
Early research (Phase 1)Study completedNCT01058993
What this trial is testing

AMD 3100 for Treatment of Myelokathexis

Who this might be right for
Neutropenia
University of Washington 6
Testing effectiveness (Phase 2)Study completedNCT01905475
What this trial is testing

CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)

Who this might be right for
Large Reperfused ST-Elevation Myocardial Infarction
Polyphor Ltd. 120
Very early researchEnded earlyNCT02069080
What this trial is testing

Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-Plerixafor

Who this might be right for
Cancer
National Institute of Allergy and Infectious Diseases (NIAID) 2
Very early researchStudy completedNCT03020524
What this trial is testing

Autologous CD4 T-Cells in HIV (C34-CXCR4)

Who this might be right for
Hiv
University of Pennsylvania 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04263480
What this trial is testing

Efficacy and Safety of Carfilzomib in Combination With Ibrutinib vs Ibrutinib in Waldenström's Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
Christian Buske 99
Testing effectiveness (Phase 2)Study completedNCT01010880
What this trial is testing

Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Biokine Therapeutics Ltd 16
Not applicableLooking for participantsNCT06254313
What this trial is testing

The Role of Cxcr4Hi neutrOPhils in InflueNza

Who this might be right for
InfluenzaAcute Respiratory Distress Syndrome
University Hospital, Bordeaux 90
Early research (Phase 1)Study completedNCT05618301
What this trial is testing

Motixafortide and Natalizumab to Mobilize CD34+ Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease (SCD)

Who this might be right for
Sickle Cell Disease
Washington University School of Medicine 10
Testing effectiveness (Phase 2)Study completedNCT00906945
What this trial is testing

Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid, Acute
Washington University School of Medicine 39
Very early researchUnknownNCT03436342
What this trial is testing

Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myeloma and Lymphoma

Who this might be right for
Multiple MyelomaLymphoma
Peking Union Medical College Hospital 100
Early research (Phase 1)Study completedNCT02179970
What this trial is testing

To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers

Who this might be right for
Pancreatic Adenocarcinoma MetastaticOvarian Serous AdenocarcinomaColorectal Cancer Metastatic
CCTU- Cancer Theme 26
Early research (Phase 1)UnknownNCT04684472
What this trial is testing

Modified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell Malignancies

Who this might be right for
Refractory B-Cell Non-Hodgkin LymphomaRefractory Leukemia
Liqun Zou 18
Early research (Phase 1)Ended earlyNCT03277209
What this trial is testing

To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas

Who this might be right for
Pancreas Cancer
Weill Medical College of Cornell University 2
Not applicableStudy completedNCT07212959
What this trial is testing

As Part of a Pilot Study, Visualization of Inflammatory Activity in Systemic Sclerosis Using CXCR4 PET/CT

Who this might be right for
Systemic Sclerosis (SSc)
Wuerzburg University Hospital 12
Early research (Phase 1)Ended earlyNCT01374503
What this trial is testing

First in Man Study of ALX-0651, a Nanobody Inhibiting CXCR4

Who this might be right for
Healthy Volunteers
Ablynx, a Sanofi company 52
Next Page